4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000065
Chief Financial Officer sold 8,637 shares at $19.98 ($172,562)
- Chief Financial Officer acquired 6,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| WENTWORTH KORY JAMES Chief Financial Officer | 2024-11-11 | Option exercise 10b5-1 | +6,000 | $2.10 | $12,600 | 82,486 | D |
| WENTWORTH KORY JAMES Chief Financial Officer | 2024-11-11 | Sale 10b5-1 | −8,637 | $19.98 | $172,562 | 73,849 | D |
| Derivatives | |||||||
| WENTWORTH KORY JAMES Chief Financial Officer | 2024-11-11 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,000 | 37,157 | D | ||
| Open-market sales · 8,637 sh · avg $19.98 · $172,562 | |||||||
Loading xslF345X05/wk-form4_1731534419.xml…